Marker Therapeutics (GX1.MU) Q1 2026 Earnings

18MarConfirmed
Q1 2026
-0.17
-0.14
-0.11
-0.09

Details

Expected EPS
-0.16641750012
Actual EPS
-0.08723600000000001
Surprise EPS
0.08
Surprise Percent
+47.58%

Description

Marker Therapeutics (GX1.MU) has reported earnings of -0.08723600000000001 per share for Q1 2026.

0 Comments

Share your thoughts